heartburn
Showing 1 - 25 of 59
Heartburn, Dyspepsia Trial in Basel (App-based treatment support)
Recruiting
- Heartburn
- Dyspepsia
- App-based treatment support
-
Basel, Basel-Stadt, SwitzerlandTopPharm Apotheke am Spalebärg
Oct 18, 2023
Gastroesophageal Reflux, Heartburn Trial in Amsterdam (LEFT smartwatch app)
Recruiting
- Gastroesophageal Reflux
- Heartburn
- LEFT smartwatch app
-
Amsterdam, Noord-Holland, NetherlandsAmsterdam UMC
Oct 3, 2023
Gastroesophageal Reflux, Regurgitation, Heartburn Trial in Jacksonville (Breath Testing)
Not yet recruiting
- Gastroesophageal Reflux
- +2 more
- Breath Testing
-
Jacksonville, FloridaMayo Clinic Florida
Jul 27, 2023
Prevalence of Fuctional Heartburn in Patients With IBS .
Not yet recruiting
- Heartburn
- (no location specified)
Jun 5, 2023
Non-Erosive Gastro-Esophageal Reflux Disease, Heartburn Trial in United States (Vonoprazan, Placebo)
Completed
- Non-Erosive Gastro-Esophageal Reflux Disease
- Heartburn
- Vonoprazan
- Placebo
-
Anniston, Alabama
- +62 more
Dec 8, 2022
Heartburn, Dyspepsia, Reflux Trial in Leuven (de-prescription of PPI via intermittent scheme, de-prescription of PPI via
Not yet recruiting
- Heartburn
- +2 more
- de-prescription of PPI via intermittent scheme
- +2 more
-
Leuven, Vlaams Brabant, BelgiumJan Tack
Nov 16, 2022
Heartburn Trial in Cleveland (Optimal Dosing of Omeprazole)
Completed
- Heartburn
- Optimal Dosing of Omeprazole
-
Cleveland, OhioMetroHealth Medical System
Oct 23, 2022
Non-Erosive Gastro-Esophageal Reflux Disease, Heartburn Trial in United States (Vonoprazan, Placebo)
Recruiting
- Non-Erosive Gastro-Esophageal Reflux Disease
- Heartburn
- Vonoprazan
- Placebo
-
Athens, Alabama
- +93 more
Aug 16, 2022
Heartburn Trial in Manassas (Panosyl-isomaltooligosaccharides (PIMO) 1g (1.4 ml), Placebo 1.4 ml)
Recruiting
- Heartburn
- Panosyl-isomaltooligosaccharides (PIMO) 1g (1.4 ml)
- Placebo 1.4 ml
-
Manassas, VirginiaMicrobiome Health Sciences
May 3, 2022
Caffeine Dependence, Anxiety, Sleep Disturbance Trial in Baltimore (Caffeine Reduction Manual)
Recruiting
- Caffeine Dependence
- +15 more
- Caffeine Reduction Manual
-
Baltimore, MarylandBehavioral Pharmacology Research Unit, Johns Hopkins Bayview Med
Mar 15, 2022
Acne, Bites, Burns Trial in Madrid (Minor ailment service)
Recruiting
- Acne
- +30 more
- Minor ailment service
-
Madrid, SpainSpanish Society of Community Pharmacy
Feb 18, 2022
Gastroesophageal; Reflux With Esophagitis, Gastroesophageal Reflux, GERD Trial in Moscow (Dietary assessment)
Recruiting
- Gastroesophageal; Reflux With Esophagitis
- +5 more
- Dietary assessment
-
Moscow, Russian FederationGastroenterology and Hepatology, FRC Nutrition and Biotechnology
Feb 2, 2022
Risk Factors After Therapeutic Biliary Interventions
Completed
- Dyspepsia
- +2 more
- upper GIT endescopy
-
Zagazig, Sharkia, EgyptZagazig University Hospitals
Nov 24, 2021
Indigestion, Heartburn Trial in New York (HLNatural, Inc. Upset Stomach Relief)
Completed
- Indigestion
- Heartburn
- HLNatural, Inc. Upset Stomach Relief
-
New York, New YorkHLNatural, Inc.
Nov 5, 2021
Dyspepsia, Heartburn Trial in Spain (Mipolixin®, Poliprotect®)
Completed
- Dyspepsia
- Heartburn
- Mipolixin®
- Poliprotect®
-
Albuñol, Spain
- +10 more
May 25, 2021
Heartburn, Acid Regurgitation Trial in Gainesville (Gastro-AD®, Placebo)
Completed
- Heartburn
- Acid Regurgitation
- Gastro-AD®
- Placebo
-
Gainesville, FloridaFood Science and Human Nutrition Department
Jun 5, 2020
Heartburn, Gastroesophageal Reflux Disease Trial in China (Dexlansoprazole, Placebo)
Completed
- Heartburn
- Gastroesophageal Reflux Disease
- Dexlansoprazole
- Placebo
-
Beijing, Beijing, China
- +24 more
Jul 3, 2019
Dyspepsia, Hematemesis, Abdominal Pain Trial in Helsinki (Anesthetics, Local, Sodium Chloride 0.9%)
Unknown status
- Dyspepsia
- +3 more
- Anesthetics, Local
- Sodium Chloride 0.9%
-
Helsinki, Uusimaa, FinlandDepartment of Anesthesiology and Intensive care medicine, Diviso
May 3, 2019
Heartburn Trial in Oklahoma City (Esomeprazole 20 mg, Placebo)
Completed
- Heartburn
- Esomeprazole 20 mg
- Placebo
-
Oklahoma City, Oklahoma
- +1 more
Mar 8, 2017
Gastroesophageal Reflux Disease (GERD), Heartburn, Dyspepsia Trial in Boston (Supplement, Placebo, Expanded Interview)
Completed
- Gastroesophageal Reflux Disease (GERD)
- +2 more
- Supplement
- +3 more
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Feb 24, 2017
Heartburn Trial in Oklahoma City (Itopride, Placebo)
Completed
- Heartburn
- Itopride
- Placebo
-
Oklahoma City, OklahomaThe Oklahoma Foundation for Digestive Research
Feb 7, 2017
Anemia, Constipation, Diarrhea Trial in London (ferrous sulfate, Placebo)
Completed
- Anemia
- +5 more
- ferrous sulfate
- Placebo
-
London, United KingdomKing's College London
Feb 3, 2017
Heartburn, Gastroesophageal Reflux Disease Trial in Chapel Hill (Dexlansoprazole)
Completed
- Heartburn
- Gastroesophageal Reflux Disease
-
Chapel Hill, North CarolinaUniversity of North Carolina at Chapel Hill
Dec 16, 2016
Gastroesophageal Reflux Disease, Heartburn, Regurgitation Trial in Indianapolis (Mucosectomy, Rubber Band Ligation)
Terminated
- Gastroesophageal Reflux Disease
- +3 more
- Mucosectomy
- Rubber Band Ligation
-
Indianapolis, IndianaIndiana University Hospital
Jun 17, 2015